Welcome to DukeHealth.org.
Skip over navigation
  • Home
  • Patient and Visitor Info
  • Physicians
  • Services
  • Clinical Trials
  • Event Calendar
  • Locations
  • Health Library
  • About Duke Medicine

Quick Links

  • Appointments
  • HealthView Patient Login
  • Quality and Safety
Home > Services > AIDS Research and Treatment Center (DART) > Programs > Clinical Trials > Observational Clinical Research Trials
Jumbo Large Regular Text:
Print
AIDS Research and Treatment Center (DART)
Progressive and compassionate care for HIV/AIDS patients and family
About Us
Programs
Peer Counseling Partners In Caring AIDS Legal Assistance Project Community Advisory Board John Bartlett Care Fund Clinical Trials
Care Guides
Physicians
Locations

Observational Clinical Research Trials

Share

The following observational clinical trials are currently open for enrollment, though the individual requirements and treatments for each study differ.

Acute HIV Longitudinal Trial

The purpose of this observational study is to provide long-term follow up of acutely/recently HIV infected patients.

Requirements for this study include:

  • Subjects with a negative antibody test three months prior to HIV+ test result

Treatment will include:

  • Observation only; no medicine will be provided during study

To become involved, contact Kara McGee:

  • Phone: 919-668-0242
  • E-mail: mcgee018@mc.duke.edu

CHAVI 001 - Acute Observation Study

Chavi 001 is an acute HIV-1 infection prospective cohort study to acquire data for HIV vaccine development.

Requirements for this study include:

  • Acutely diagnosed
  • Control cohort HIV+/HIV-

Treatment will include:

  • Observation only

To become involved, contact Kara McGee:

  • Phone: 919-668-0242
  • E-mail: mcgee018@mc.duke.edu

CHAVI 012 - Acute, Chronic, Uninfected

Acute infection observation study. One visit with possible follow-up.

Requirements for this study include:

  • Acutely diagnosed within six months
  • May be treatment naïve or on treatment

Possible procedures compensated by study:

  • Colonoscopy with biopsy
  • Bone marrow aspirate
  • Leukopheresis

To become involved, contact Kara McGee:

  • Phone: 919-668-0242
  • E-mail: mcgee018@mc.duke.edu

CHAVI 008

The Chavi B-cell study intends to assess the immune systems of chronically infected patients to inform development of an HIV vaccine.

Requirements for this study include:

  • Any CD4 count
  • On or off ARVs

Treatment will include:

  • Observational study; one time blood draw

To become involved, contact Kara McGee:

  • Phone: 919-668-0242
  • E-mail: mcgee018@mc.duke.edu

Fatty Acid Study

Comparison of fatty acid profile before and three months after initiation of ritonavir.

Requirements for this study include:

  • Must be new to, or have been off ritonavir for >3 months

Treatment will include:

  • Observational study

To become involved, contact Debbie McMullen:

  • Phone: 919-668-3759
  • E-mail: mcmul006@mc.duke.edu
Contact Us | Careers | Privacy Policy | Make a Gift | Site Map | RSS Feeds | En Español | Mobile Site | Help
Duke Medicine | Duke School of Medicine | Duke Children's | Duke University
Toll-Free: 888-ASK-DUKE (888-275-3853)
Copyright © 2004-2013 Duke University Health System

About This Page

Updated: Sept. 29, 2010
Published: Aug. 16, 2007
URL: http://www.dukehealth.org/services/dart/programs/clinical_trials/observational_clinical_trials